Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Bought by Meeder Asset Management Inc.

Meeder Asset Management Inc. boosted its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 104.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,547 shares of the company’s stock after buying an additional 4,879 shares during the period. Meeder Asset Management Inc.’s holdings in Nu Skin Enterprises were worth $599,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. BlackRock Inc. increased its stake in shares of Nu Skin Enterprises by 21,593.4% in the first quarter. BlackRock Inc. now owns 6,683,531 shares of the company’s stock valued at $371,201,000 after buying an additional 6,652,722 shares during the period. Schroder Investment Management Group increased its stake in shares of Nu Skin Enterprises by 139.4% in the first quarter. Schroder Investment Management Group now owns 1,711,619 shares of the company’s stock valued at $94,687,000 after buying an additional 996,731 shares during the period. Vanguard Group Inc. increased its stake in shares of Nu Skin Enterprises by 11.8% in the first quarter. Vanguard Group Inc. now owns 6,011,632 shares of the company’s stock valued at $333,887,000 after buying an additional 634,951 shares during the period. State Street Corp increased its stake in shares of Nu Skin Enterprises by 76.7% in the first quarter. State Street Corp now owns 1,416,873 shares of the company’s stock valued at $78,695,000 after buying an additional 614,817 shares during the period. Finally, Norges Bank purchased a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $27,260,000. Institutional investors and hedge funds own 85.51% of the company’s stock.

Nu Skin Enterprises, Inc. (NUS) opened at 63.57 on Thursday. The firm has a market cap of $3.36 billion, a price-to-earnings ratio of 21.10 and a beta of 1.32. The stock’s 50 day moving average is $60.67 and its 200 day moving average is $55.02. Nu Skin Enterprises, Inc. has a 52 week low of $46.35 and a 52 week high of $66.04.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.01. Nu Skin Enterprises had a net margin of 7.48% and a return on equity of 23.45%. The business had revenue of $499.10 million for the quarter, compared to analyst estimates of $493.65 million. During the same quarter in the previous year, the firm posted $0.42 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities research analysts expect that Nu Skin Enterprises, Inc. will post $3.12 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Bought by Meeder Asset Management Inc.” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/07/20/nu-skin-enterprises-inc-nysenus-shares-bought-by-meeder-asset-management-inc.html.

NUS has been the subject of several research analyst reports. Sidoti downgraded shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 price target for the company. in a research report on Wednesday, April 26th. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, May 6th. Pivotal Research reiterated a “buy” rating and issued a $80.00 target price (up previously from $65.00) on shares of Nu Skin Enterprises in a research report on Thursday, June 22nd. Finally, Deutsche Bank AG increased their target price on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the stock a “buy” rating in a research report on Wednesday, June 21st. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $62.25.

In other news, General Counsel D Matthew Dorny sold 8,000 shares of the stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $56.39, for a total value of $451,120.00. Following the completion of the transaction, the general counsel now owns 52,730 shares of the company’s stock, valued at $2,973,444.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 24,250 shares of company stock worth $1,436,770 over the last quarter. Corporate insiders own 5.20% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply